2nd Quarter - Report

BRAEBURN INC. FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC for BRAEBURN INC FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC

Firm
Client
Income
—
Expenses
$140,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

S 1895: Lower Health Care Costs Act in reference to the Opioid Crisis

LobbyistCovered position, as disclosed
EDWARD BUCKLEY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

S 1895: Lower Health Care Costs Act in reference to the Opioid Crisis

LobbyistCovered position, as disclosed
EDWARD BUCKLEY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Alcohol and Drug Abuse ALC

S 1895: Lower Health Care Costs Act in reference to the Opioid Crisis

LobbyistCovered position, as disclosed
EDWARD BUCKLEY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Insurance INS

S 1895: Lower Health Care Costs Act in reference to the Opioid Crisis

LobbyistCovered position, as disclosed
EDWARD BUCKLEY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

S 1895: Lower Health Care Costs Act in reference to the Opioid Crisis

LobbyistCovered position, as disclosed
EDWARD BUCKLEY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.